HopeStage
Back to all studies
WithdrawnNCT02286206

Study of the Effect of Dosing on Clozapine Levels

Medication studyAges 19–65CanadaSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 19 years to 65 years.

Listed locations
VancouverSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateJanuary 2015
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
University of British Columbia
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Canada
Age range
From 19 Years to 65 Years
Official registry ID
NCT02286206
Official title
Show the full official title

A Pilot Study to Determine How Frequency of Administration Modifies Steady-State Plasma Concentrations of Orally Administered Clozapine

Recruitment & locations

Withdrawn

Vancouver

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of British Columbia, a university.

Does this study involve medication?

Yes. The study involves medication, including Clozapine.

Who can participate?

Listed age limits: 19 years to 65 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies